Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-09-22 DORSA CAROLINE Director Exercise or conversion · Stock Option (Right to Buy) −2,570 0
2016-09-22 DORSA CAROLINE Director Exercise or conversion · Stock Option (Right to Buy) −25,000 0
2016-07-21 SCANGOS GEORGE A Chief Executive Officer Sale −157 $280.00 $44K 54,779
2016-06-08 DENNER ALEXANDER J Director Grant or award +1,060 8,950
2016-06-08 SHERWIN STEPHEN A Director Grant or award +1,060 5,905
2016-06-08 SCHENK LYNN Director Grant or award +1,060 5,950
2016-06-08 Rowinsky Eric K Director Grant or award +1,060 13,065
2016-06-08 PAPADOPOULOS STELIOS Director Grant or award +1,590 18,170
2016-06-08 Mulligan Richard Director Grant or award +1,060 8,950
2016-06-08 LEAMING NANCY Director Grant or award +1,060 8,984
2016-06-08 DORSA CAROLINE Director Grant or award +1,060 17,093
2016-06-08 PANGIA ROBERT W Director Grant or award +1,060 16,628
2016-06-08 Posner Brian S Director Grant or award +1,060 6,335
2016-06-06 Koppel Adam EVP, Strategy and Bus. Dev. Sale −555 $290.00 $161K 2,402.11
2016-06-03 SCANGOS GEORGE A Chief Executive Officer Sale −842 $290.00 $244K 54,936
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion +1,643 3,491.11
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Shares withheld for taxes −534 $289.73 $155K 2,957.11
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Exercise or conversion · Restricted Stock Unit −1,643 5,585
2016-06-02 Koppel Adam EVP, Strategy and Bus. Dev. Other disposition · Restricted Stock Unit −1,969 3,616
2016-06-01 Ehlers Michael D EVP, Research and Development Grant or award +3,034 3,034

Page 69 of 73 · 1,456 trades